Michael F Mahoney sold $15M of BSX
Chairman, President & CEO at BOSTON SCIENTIFIC CORP. 160,901 shares at an average of $93.49, traded Feb 2, 2026, filed Feb 3, 2026.
Score components
- +25RoleCEO
- +25Trade size$15.0M at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-26-001156, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | MOption exercise Common Stock10b5-1 | +49,407 | $24.55 | $1.2M | 1,526,289 | Feb 3, 2026 |
| Feb 2, 2026 | MOption exercise Common Stock10b5-1 | +46,347 | $27.09 | $1.3M | 1,572,636 | Feb 3, 2026 |
| Feb 2, 2026 | SOpen-market sale Common Stock10b5-1 | -1,200 | $94.06 | $113k | 1,571,436 | Feb 3, 2026 |
| Feb 2, 2026 | SOpen-market sale Common Stock10b5-1 | -159,701 | $93.49 | $15M | 1,411,735 | Feb 3, 2026 |
| Feb 2, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -46,347 | $0.00 | $0 | 231,739 | Feb 3, 2026 |
| Feb 2, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -49,407 | $0.00 | $0 | 98,814 | Feb 3, 2026 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,313 shares | -42% | |
| 38Weak | BOSTON SCIENTIFIC CORP | Ellen M Zane director | $1.3M 12,891 shares | -35% | |
| 18Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.0M 50,000 shares | -22% | |
| 38Weak | BOSTON SCIENTIFIC CORP | Ellen M Zane director | $1.3M 12,891 shares | -35% | |
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $4.9M 50,000 shares | -22% | |
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.3M 50,000 shares | -22% | |
| 40Moderate | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,313 shares | -42% | |
| 25Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.2M 50,000 shares | -22% | |
| 64Notable | BOSTON SCIENTIFIC CORP | Yoshiaki Fujimori director | $310k 2,901 shares | -58% | |
| 51Moderate | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $424k 4,000 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.